Skip to main content

Table 2 Adverse and intercurrent events at 3 years

From: Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn’s disease

Events

n (%)

Perianal pain

4 (40%)

Local inflammation

4 (40%)

New fistula tract

1 (10%)

Abscess

3 (30%)

1

2 (20%)

 > 1

1 (10%)

Luminal surgery

2 (20%)

Anal surgery

4 (40%)

Drainage with setons

3 (30%)

Fistulotomy

1 (10%)

Change of biotherapy

2 (20%)

Hospitalization

4 (40%)

1

2 (20%)

 > 1

2 (20%)

Antibiotic therapy

2 (20%)

Steroids

0 (0%)